SOM.AX Shariah Compliance

Screening Methodology: AAOIFI

lock image
LOCKED

Analyst's Ratings

Based on 6 analysts giving stock ratings to Somnomed Ltd in the past 3 months

Strong
Sell
SellHoldBuyStrong
Buy
Strong Buy
17
Buy
66
Hold
17
Sell
0
Strong Sell
0
Somnomed Ltd

Somnomed Ltd. Stock Analysis SOM.AX

Australia Health Care Micro Cap
SomnoMed Ltd. engages in the production and sale of devices for the oral treatment of sleep related disorders. The company is headquartered in Sydney, New South Wales. The company went IPO on 2004-08-27. The company provides treatment solutions for sleep-related breathing disorders, including obstructive sleep apnea, snoring, and bruxism. The company is focused on the commercialization of the SomnoDent Mandibular Advancement Splint and other oral devices for sleep related disorders. Its segments include North America, Europe, Asia Pacific, CORE, and RSS. Its SomnoDent product line includes SomnoDent Avant, SomnoDent Classic, SomnoDent Flex, SomnoDent Fusion, Herbst Advance Elite and Herbst Advance. Its SomMorning Repositioner is designed to help return their mandible back to its pre-treatment centric position. Its SomnoBrux Michigan splint is a custom fit, acrylic splint (dental guard) for upper teeth designed to protect the teeth from grinding and scraping during Bruxism. The company also offers SomTabs, which are cleaning tablets that are developed to clean oral appliances.
Read More

SOM.AX Chart

Australia Health Care Micro Cap

Somnomed Ltd vs S&P/ASX 200 Comparative Returns

Analysis of SOM.AX stock performance compared to the broader market (S&P/ASX 200) across multiple timeframes.

YTD Performance
  • Somnomed Ltd... (SOM...) 19.57%
  • S&P/ASX 200 -0.61%
Somnomed Ltd Outperformed S&P/ASX 200 by 20.18%
1Y Performance
  • Somnomed Ltd... (SOM...) 111.54%
  • S&P/ASX 200 5.12%
Somnomed Ltd Outperformed S&P/ASX 200 by 106.42%
3Y Performance
  • Somnomed Ltd... (SOM...) -61.91%
  • S&P/ASX 200 13.84%
Somnomed Ltd Underperformed S&P/ASX 200 by 75.75%
5Y Performance
  • Somnomed Ltd... (SOM...) -43.06%
  • S&P/ASX 200 51.09%
Somnomed Ltd Underperformed S&P/ASX 200 by 94.15%

Key Statistics

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

AUD0.55AUD0.57

Today's Open

AUD0.57

Volume

4657.00

P/E Ratio (TTM)

-

52 Week Range

AUD0.19AUD0.70

Market Cap

110.22M

Avg. Volume

12.69K

Dividend Yield

-

FAQ's

Halal stocks refer to shares of companies that comply with Islamic finance principles, meaning they do not engage in businesses related to alcohol, gambling, pork, or interest-based financial services.